Related Experiment Video
Updated: Jul 10, 2026

Spontaneous Murine Model of Anaplastic Thyroid Cancer
Published on: February 3, 2023
[Gene abnormalities in thyroid cancer]
Hiroyuki Namba1, Shunichi Yamashita
1Department of Molecular Medicine, Atomic Bomb Disease Institute, Nagasaki University Graduate School of Biomedical Science.
Abstract:
A number of genetic abnormalities in oncogenes or anti-oncogenes have been identified in association with thyroid carcinogenesis. Especially, oncogenes such as ras mutation, ret/PTC and Braf mutation that constitutively activate MAP kinase pathway a refrequently found in papillary thyroid cancer. The p53 mutation aggravates differentiated thyroid cancers to anaplastic thyroid cancer. These gene alterations are studied not only to understand basically the mechanisms of oncogenesis but also to develop clinically genetic diagnosis or molecular target therapy. In this article, we review the genetic diagnostic methods and phenotype-genotype relationship of human thyroid cancers.
Insights
Genetic alterations in oncogenes and tumor suppressors drive thyroid cancer. Understanding these mutations, like BRAF and RAS, aids in developing targeted therapies and genetic diagnostics for thyroid cancer.
Area of Science:
- Oncology
- Genetics
- Molecular Biology
Background:
- Thyroid cancer development involves genetic abnormalities in oncogenes and tumor suppressor genes.
- Key oncogenes like RAS, RET/PTC, and BRAF mutations are frequently observed in papillary thyroid cancer, activating the MAP kinase pathway.
- TP53 mutations are associated with the progression of differentiated thyroid cancers to anaplastic thyroid cancer.
Purpose of the Study:
- To review genetic diagnostic methods for human thyroid cancers.
- To explore the relationship between the phenotype and genotype of thyroid cancers.
- To understand the fundamental mechanisms of oncogenesis and inform clinical applications.
Main Methods:
- Review of existing literature on genetic alterations in thyroid carcinogenesis.
- Analysis of genotype-phenotype correlations in thyroid cancer.
- Discussion of current and emerging genetic diagnostic techniques.
Main Results:
- Specific gene mutations (RAS, RET/PTC, BRAF, TP53) are strongly linked to thyroid cancer subtypes and progression.
- These genetic alterations provide insights into the molecular pathways driving thyroid tumorigenesis.
- Genetic profiling is crucial for understanding thyroid cancer heterogeneity.
Conclusions:
- Genetic alterations are fundamental to thyroid carcinogenesis and cancer progression.
- Knowledge of these genetic changes is essential for advancing genetic diagnosis and molecular targeted therapies for thyroid cancer.
- Further research into genotype-phenotype relationships will refine clinical management strategies.
Related Concept Videos
Goiter
Graves' Disease I: Introduction
Cancers Originate from Somatic Mutations in a Single Cell
Cancers Originate from Somatic Mutations in a Single Cell
Graves Disease II: Pathophysiology
Abnormal Proliferation

